StockWatch
·

Taylormade Renewables Ltd Q2 FY26 Results

TRLQ2 FY26 Results
Filing
MetricValue (₹ Cr)vs Q1 FY26
Revenue-1.72110.3%
Total Income4.5273.1%
Expenditure9.1239.7%
PBT-4.60377.6%
Net Profit-4.60547.1%
OPM100.00%86.79pp
NPM—
EPS3.71550.9%
View full financials

Taylormade Renewables Q2 FY 2025-26 Results: High Profit Margins and BOO Vertical Expansion

16 Nov 2025 · 16 Nov 2025, 07:02 pm

Summary

Taylormade Renewables Limited's Q2 FY 2025-26 results showed high profit margins and the addition of the BOO Project vertical to its Product business. The first BOO project has shown promising results. The company wrote off remaining revenues from Andra Pradesh, leading to an adjustment in the consolidated revenue. TEPL, the company's subsidiary, achieved a turnover of INR 771.9 lakhs in Q2 FY 2026 and is expected to improve profitability as operations stabilize. TRL secured an INR 23.9 crore order from SGL Resources and expects to achieve a lifetime high revenue in H2 FY 2026.

Key Highlights

  1. 1

    Q2 FY 2026 results marked a significant milestone in Taylormade Renewable’s strategic evolution

  2. 2

    Company added BOO Project vertical to its Product business

  3. 3

    Initial results from the first BOO project are promising

  4. 4

    Management decided to write off remaining portion of revenues booked from Andra Pradesh

  5. 5

    TEPL achieved turnover of INR 771.9 lakhs in Q2 FY 2026

  6. 6

    TRL secured INR 23.9 crore order from SGL Resources

  7. 7

    TRL expects to achieve their lifetime high revenue in H2 FY 2026

Management Comments

D

Dharmendra Sharad Gor

The management appreciates the confidence exhibited by all the stakeholders over last 24 months as TRL pivoted its strategy from EPC driven expansion to BOO led growth. TEPL has served as a strong proof of concept for BOO Vertical and its ability to deliver steady growth and cash flows. The management expects that H2 FY 2026 performance will further enhance stakeholder confidence in TRL.

Informational and educational content only. Not investment advice.